APR 02, 2018 8:37 PM PDT

'Fish Hooks' Speed Up Drug Discovery

WRITTEN BY: Nouran Amin

 

DNA-encoded chemical library (DECL), containing about 35 million different drugs, is a new screening method developed to speed up drug discovery.

The collection of drug candidates consist of basic ring-shaped structures based on the work of Manfred Mutter from the University of Lausanne where three different molecules were attached to one side of each ring structure. “Together, they form a kind of highly-specific fish hook that can bind onto a protein if its form perfectly matches the protein’s structure,” says lead researcher Jörg Scheuermann of ETH Zurich. Now, DECL researchers use the library for all kinds of “fish hooks” creating various combinations.

Investigators encoded the blueprint of these molecules in short DNA sequences where the genetic material was bound to the reverse of the basic structure producing an artificial piece of DNA that serves as a “barcode”. Investigators can use such barcode to identify each fish hook individually. This can allow the ability to detect a target protein caught by one of the “fish hooks”. So, researchers placed all 35 million compounds a reaction vessel containing the protein of interest. After a period of time ,they washed the chemical collection away hoping that those drugs that failed to bind to the carrier protein were discarded, and those that succeeded in binding remained in the vessel. Those drugs that were not washed away were identified using DNA barcodes. The identifications of those remaining in the sample can allow researchers to further potential testing and narrow down their options until a match is made.

Image via Phys.org

The development of DECLs was in works for years. The basics of DECLs which are the essential foundations of DNA-encoding were first described in the early 1990s by Scripps researchers Richard Lerenr and Sidney Brenner but was not put into practice until a decade later when researchers at Harvard University worked on the idea and later presented the first DNA-encoding chemical collection.

The progress of DECL has been crucial in the pharmaceutical industry due to its inexpensiveness and efficacy. “The design of our DECL is based on the fact that we wanted to generate a new molecule form that would be functionally equivalent to an antibody reduced to its minimum size, and therefore accessible via chemical synthesis,” explains Scheuermann. “By using molecules that possess three or more chemical hooks, we come closer to antigen-antibody interactions.”

A proposed treatment option involves linking a particular protein known as a cytotoxin to a small-molecule drug conjugate, protein binder. This approach allows the cytotoxin to recognize a foreign invader or tumor cell, bind to it, and release the toxic activity in a localized concentration, leading to tumor cellular death. This method was previously used with antibodies as antibody-drug conjugates (ADC).“However, as antibodies are relatively large, they were not able to penetrate tumor tissue well; small molecules should be able to accomplish this better,” explains Scheuermann.

Sources: Nature Chemistry

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 23, 2019
Technology
NOV 23, 2019
Can artificial intelligence increase tuberculosis drug development?
It’s no secret that there is a shortage of tuberculosis drug development. To combat this issue, researchers at the University of Michigan designed a ...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
IV Treatment for Traumatic Brain Injury
Scientists are now using exosomes intravenously as a method of cell-to-cell technology for treating patients with traumatic brain injury (TBI). They discov...
DEC 23, 2019
Cell & Molecular Biology
DEC 23, 2019
An Antioxidant Found in Green Tea Can Fight Tuberculosis
In 2018, around ten million people around the globe were sickened by tuberculosis (TB) and about 1.5 million people were killed by tuberculosis....
DEC 23, 2019
Drug Discovery & Development
DEC 23, 2019
FDA Approves New Schizophrenic Drug
The US Food and Drug Administration (FDA) has approved an atypical antipsychotic Caplyta (lumateperone; Intra-Cellular Therapies) for the treating schizoph...
DEC 27, 2019
Microbiology
DEC 27, 2019
Using a Cancer Drug to Fight Antibiotic-Resistant Pathogens
It takes a long time for a drug to be approved for use in humans; repurposing existing drugs is one way to get around that hurdle....
FEB 11, 2020
Cannabis Sciences
FEB 11, 2020
Traffic Light System Best Way to Label Cannabis Edibles
Cannabis products have become increasingly popular. Yet, as they are still relatively new to the market, research has found that most consumers don’t...
Loading Comments...